Friedrich W. Mohr

Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease

Patrick W. Serruys, Marie‐Claude Morice, A. Pieter Kappetein et al. · New England Journal of Medicine · 2009 · 4.3K citations · Full text

Medicine, Cardiology, Surgery +13

Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial

Friedrich W. Mohr, Marie-Claude Morice, A. Pieter Kappetein et al. · The Lancet · 2013 · 1.8K citations

Medicine, Cardiology, Surgery +13

Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II

Vasim Farooq, David van Klaveren, Ewout W. Steyerberg et al. · The Lancet · 2013 · 827 citations

Medicine, Cardiology, Surgery +17

Outcomes in Patients With De Novo Left Main Disease Treated With Either Percutaneous Coronary Intervention Using Paclitaxel-Eluting Stents or Coronary Artery Bypass Graft Treatment in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial

Marie-Claude Morice, Patrick W. Serruys, A. Pieter Kappetein et al. · Circulation · 2010 · 644 citations

Medicine, Cardiology, Surgery +13

Stroke after cardiac surgery: a risk factor analysis of 16,184 consecutive adult patients

Jan Bucerius, Jan Gummert, Michael A. Borger et al. · The Annals of Thoracic Surgery · 2003 · 623 citations

Medicine, Cardiology, Surgery +15